hypericin has been researched along with Infarct in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypericin (Hy) has shown great promise as a necrosis-avid agent in cancer imaging and therapy." | 3.81 | Evaluation of hypericin: effect of aggregation on targeting biodistribution. ( Gao, M; Huang, D; Ji, Y; Jiang, C; Li, Y; Liu, W; Liu, X; Ni, Y; Sun, Z; Yao, N; Yin, Z; Zhang, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, X | 1 |
| Jiang, C | 1 |
| Li, Y | 1 |
| Liu, W | 1 |
| Yao, N | 1 |
| Gao, M | 1 |
| Ji, Y | 1 |
| Huang, D | 1 |
| Yin, Z | 1 |
| Sun, Z | 1 |
| Ni, Y | 1 |
| Zhang, J | 1 |
1 other study available for hypericin and Infarct
| Article | Year |
|---|---|
Evaluation of hypericin: effect of aggregation on targeting biodistribution.
Topics: Animals; Anthracenes; Antineoplastic Agents, Phytogenic; Autoradiography; Dimethyl Sulfoxide; Drug C | 2015 |